Europe
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 355.72 B
|
Dec. 31, 2023 | USD 96.52 | 1.53% |
|
Germany |
|
2 |
USD 316.62 B
|
Dec. 31, 2023 | USD 32.63 | 0.46% |
|
United Kingdom |
|
3 |
USD 218.94 B
|
Dec. 31, 2023 | USD 57.30 | 0.03% |
|
France |
|
4 |
USD 217.83 B
|
Dec. 31, 2023 | USD 4.49 | 1.09% |
|
Switzerland |
|
5 |
USD 209.21 B
|
Dec. 31, 2023 | USD 12.45 | 0.97% |
|
Netherlands |
|
6 |
USD 208.35 B
|
Dec. 31, 2023 | USD 5.13 | -2.45% |
|
United Kingdom |
|
7 |
USD 171.63 B
|
Dec. 31, 2023 | USD 78.31 | 0.29% |
|
Germany |
|
8 |
USD 169.11 B
|
Dec. 31, 2023 | USD 57.25 | 0.79% |
|
Germany |
|
9 |
USD 137.57 B
|
Dec. 31, 2023 | USD 304.65 | 1.19% |
|
Germany |
|
10 |
USD 122.86 B
|
Dec. 31, 2023 | USD 31.12 | 1.79% |
|
Germany |
|
11 |
USD 119.11 B
|
Dec. 31, 2023 | USD 45.19 | 3.75% |
|
Germany |
|
12 |
USD 110.88 B
|
Dec. 31, 2023 | USD 81.24 | 0.39% |
|
Switzerland |
|
13 |
USD 106.85 B
|
Dec. 31, 2023 | USD 25.53 | -2.05% |
|
Norway |
|
14 |
USD 103.44 B
|
Dec. 31, 2023 | USD 14.16 | -0.34% |
|
Italy |
|
15 |
USD 103.41 B
|
Dec. 31, 2023 | USD 10.87 | 1.08% |
|
Germany |
|
16 |
USD 102.52 B
|
Dec. 31, 2023 | USD 7.13 | 1.04% |
|
Italy |
|
17 |
USD 97.85 B
|
Dec. 31, 2023 | USD 33.48 | 1.20% |
|
Netherlands |
|
18 |
USD 95.09 B
|
Dec. 31, 2023 | USD 626.61 | 1.10% |
|
France |
|
19 |
USD 95.09 B
|
Dec. 31, 2023 | USD 670.93 | 1.32% |
|
France |
|
20 |
USD 94.94 B
|
Dec. 31, 2023 | USD 34.69 | 1.15% |
|
France |
|
21 |
USD 94.53 B
|
Dec. 31, 2023 | USD 12.17 | 1.23% |
|
Poland |
|
22 |
USD 93.50 B
|
Dec. 31, 2023 | USD 14.41 | 1.33% |
|
France |
|
23 |
USD 91.13 B
|
Dec. 31, 2023 | USD 16.20 | 0.10% |
|
France |
|
24 |
USD 90.24 B
|
Dec. 31, 2023 | USD 34.06 | -0.83% |
|
Germany |
|
25 |
USD 86.08 B
|
Feb. 29, 2024 | USD 4.35 | -0.91% |
|
United Kingdom |
|
26 |
USD 84.54 B
|
Sept. 30, 2024 | USD 199.90 | 1.01% |
|
Germany |
|
27 |
USD 77.14 B
|
Dec. 31, 2023 | USD 102.17 | 0.99% |
|
France |
|
28 |
USD 76.05 B
|
Dec. 31, 2023 | USD 43.81 | 2.24% |
|
Germany |
|
29 |
USD 74.69 B
|
Dec. 31, 2023 | USD 579.92 | 1.30% |
|
Switzerland |
|
30 |
USD 72.24 B
|
Dec. 31, 2023 | USD 160.75 | 0.95% |
|
Netherlands |
|
31 |
USD 71.79 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
32 |
USD 68.28 B
|
Dec. 31, 2023 | USD 22.51 | 1.02% |
|
Luxembourg |
|
33 |
USD 66.36 B
|
Nov. 30, 2024 | USD 348.99 | -0.04% |
|
Ireland |
|
34 |
USD 66.09 B
|
Dec. 31, 2023 | USD 4.83 | 2.80% |
|
Spain |
|
35 |
USD 65.93 B
|
Dec. 31, 2023 | USD 62.67 | 2.58% |
|
France |
|
36 |
USD 65.79 B
|
Dec. 31, 2023 | USD 54.69 | -1.04% |
|
United Kingdom |
|
37 |
USD 65.06 B
|
Dec. 31, 2023 | USD 12.03 | -1.34% |
|
Spain |
|
38 |
USD 64.69 B
|
Dec. 31, 2023 | USD 501.70 | 1.27% |
|
Germany |
|
39 |
USD 63.14 B
|
Dec. 31, 2023 | USD 29.57 | 2.14% |
|
Italy |
|
40 |
USD 63.02 B
|
Dec. 31, 2023 | USD 9.76 | 0.20% |
|
United Kingdom |
|
41 |
USD 61.87 B
|
Dec. 31, 2023 | USD 29.69 | 0.40% |
|
France |
|
42 |
USD 61.69 B
|
Dec. 31, 2023 | USD 39.40 | 2.24% |
|
Germany |
|
43 |
USD 59.38 B
|
Dec. 31, 2023 | USD 46.44 | -0.28% |
|
Belgium |
|
44 |
USD 57.81 B
|
Dec. 31, 2023 | USD 48.09 | 2.45% |
|
France |
|
45 |
USD 54.56 B
|
Dec. 31, 2023 | USD 24.72 | 1.01% |
|
Sweden |
|
46 |
USD 54.45 B
|
Dec. 31, 2023 | USD 13.53 | 0.53% |
|
Spain |
|
47 |
USD 54.04 B
|
Dec. 31, 2023 | USD 60.04 | 0.77% |
|
United Kingdom |
|
48 |
USD 52.92 B
|
Dec. 31, 2023 | USD 86.82 | 1.25% |
|
France |
|
49 |
USD 52.58 B
|
Dec. 31, 2023 | USD 20.20 | -1.60% |
|
Germany |
|
50 |
USD 51.73 B
|
Dec. 31, 2023 | USD 27.62 | 3.50% |
|
Germany |
The company in Europe with the highest Revenue is Volkswagen AG (XETRA: VOW.DE) at USD 355.72 B.
The company in Europe with the lowest Revenue is ImmuPharma plc (LSE: IMM.L) at USD 0.00.
The top 10 companies in Europe by Revenue are Volkswagen AG, Shell plc, TotalEnergies SE, Glencore plc, Stellantis N.V., BP p.l.c., Bayerische Motoren Werke Aktiengesellschaft, Mercedes-Benz Group AG, Allianz SE and Deutsche Telekom AG.
The bottom 10 companies in Europe by Revenue are ImmuPharma plc, Zegona Communications plc, Modus Therapeutics Holding AB (publ), Pharvaris N.V., Readcrest Capital AG, Biotalys NV, Herantis Pharma Oyj, Landore Resources Limited, Rockhopper Exploration plc and Petrel Resources Plc.